{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:03:00Z","timestamp":1790596980960,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Gout is a highly hereditary disease, but not all those carrying well-known risk variants have developing gout attack even in hyperuricemia status. We performed a genome-wide association study (GWAS) and polygenic risk score (PRS) analysis to illustrate the new genetic architectures of gout and asymptomatic hyperuricemia (AH).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>GWAS was performed to identify variants associated with gout\/AH compared with normouricemia. The participants were males, enrolled from the Taiwan Biobank and China Medical University, and divided into discovery (<jats:italic>n<\/jats:italic>=39,594) and replication (<jats:italic>n<\/jats:italic>=891) cohorts for GWAS. For PRS analysis, the discovery cohort was grouped as base (<jats:italic>n<\/jats:italic>=21,814) and target (<jats:italic>n<\/jats:italic>=17,780) cohorts, and the score was estimated by grouping the polymorphisms into protective or not for the phenotypes in the base cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The genes<jats:italic>ABCG2<\/jats:italic>and<jats:italic>SLC2A9<\/jats:italic>were found as the major genetic factors governing gouty and AH, and even in those carrying the rs2231142 (<jats:italic>ABCG2<\/jats:italic>) wild-genotype. Surprisingly, variants on chromosome 1, such as rs7546668 (<jats:italic>DNAJC16<\/jats:italic>), rs10927807 (<jats:italic>AGMAT<\/jats:italic>), rs9286836 (<jats:italic>NUDT17<\/jats:italic>), rs4971100 (<jats:italic>TRIM46<\/jats:italic>), rs4072037 (<jats:italic>MUC1<\/jats:italic>), and rs2974935 (<jats:italic>MTX1<\/jats:italic>), showed significant associations with gout in both discovery and replication cohorts (all<jats:italic>p<\/jats:italic>-values &lt; 1e\u22128). Concerning the PRS, the rates of gout and AH increased with increased quartile PRS in those SNPs having risk effects on the phenotypes; on the contrary, gout\/AH rates decreased with increased quartile PRS in those protective SNPs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We found new variants on chromosome 1 significantly relating to gout, and PRS predicts the risk of developing gout\/AH more robustly based on the SNPs\u2019 effect types on the trait.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-022-02917-4","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T05:02:44Z","timestamp":1665464564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study"],"prefix":"10.1186","volume":"24","author":[{"given":"Ya-Sian","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuu-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Gowth","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-3249","authenticated-orcid":false,"given":"Shun-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"2917_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/annrheumdis-2016-209632","volume":"76","author":"A Nakayama","year":"2017","unstructured":"Nakayama A, Nakaoka H, Yamamoto K, Sakiyama M, Shaukat A, Toyoda Y, Okada Y, Kamatani Y, Nakamura T, Takada T, et al. GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Ann Rheum Dis. 2017;76:869\u201377.","journal-title":"Ann Rheum Dis"},{"key":"2917_CR2","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1093\/hmg\/ddr307","volume":"20","author":"A Tin","year":"2011","unstructured":"Tin A, Woodward OM, Kao WH, Liu CT, Lu X, Nalls MA, Shriner D, Semmo M, Akylbekova EL, Wyatt SB, et al. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet. 2011;20:4056\u201368.","journal-title":"Hum Mol Genet"},{"key":"2917_CR3","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372:1953\u201361.","journal-title":"Lancet"},{"key":"2917_CR4","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.1038\/ncomms8041","volume":"6","author":"C Li","year":"2015","unstructured":"Li C, Li Z, Liu S, Wang C, Han L, Cui L, Zhou J, Zou H, Liu Z, Chen J, et al. Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese. Nat Commun. 2015;6:7041.","journal-title":"Nat Commun"},{"key":"2917_CR5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/ard.2008.093252","volume":"68","author":"SJ Chang","year":"2009","unstructured":"Chang SJ, Tsai MH, Ko YC, Tsai PC, Chen CJ, Lai HM. The cyclic GMP-dependent protein kinase II gene associates with gout disease: identified by genome-wide analysis and case-control study. Ann Rheum Dis. 2009;68:1213\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2917_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10863-012-9490-8","volume":"45","author":"N de Pedro","year":"2013","unstructured":"de Pedro N, Cautain B, Melguizo A, Cortes D, Vicente F, Genilloud O, Tormo JR, Pelaez F. Analysis of cytotoxic activity at short incubation times reveals profound differences among annonaceus acetogenins, inhibitors of mitochondrial Complex I. J Bioenerg Biomembr. 2013;45:145\u201352.","journal-title":"J Bioenerg Biomembr"},{"key":"2917_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A Kottgen","year":"2013","unstructured":"Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D, O\u2019Seaghdha CM, Haller T, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45:145\u201354.","journal-title":"Nat Genet"},{"key":"2917_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng.2352","volume":"44","author":"Y Okada","year":"2012","unstructured":"Okada Y, Sim X, Go MJ, Wu JY, Gu D, Takeuchi F, Takahashi A, Maeda S, Tsunoda T, Chen P, et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat Genet. 2012;44:904\u20139.","journal-title":"Nat Genet"},{"key":"2917_CR9","doi-asserted-by":"publisher","first-page":"21440","DOI":"10.1038\/srep21440","volume":"6","author":"AK Giri","year":"2016","unstructured":"Giri AK, Banerjee P, Chakraborty S, Kauser Y, Undru A, Roy S, Parekatt V, Ghosh S, Tandon N, Bharadwaj D. Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes. Sci Rep. 2016;6:21440.","journal-title":"Sci Rep"},{"key":"2917_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1755-8794-7-10","volume":"7","author":"B Yang","year":"2014","unstructured":"Yang B, Mo Z, Wu C, Yang H, Yang X, He Y, Gui L, Zhou L, Guo H, Zhang X, et al. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med Genomics. 2014;7:10.","journal-title":"BMC Med Genomics"},{"key":"2917_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194044","volume":"13","author":"J Lee","year":"2018","unstructured":"Lee J, Lee Y, Park B, Won S, Han JS, Heo NJ. Genome-wide association analysis identifies multiple loci associated with kidney disease-related traits in Korean populations. PLoS One. 2018;13: e0194044.","journal-title":"PLoS One"},{"key":"2917_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","volume":"17","author":"TR Merriman","year":"2015","unstructured":"Merriman TR. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther. 2015;17:98.","journal-title":"Arthritis Res Ther"},{"key":"2917_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10157-013-0806-8","volume":"18","author":"H Yano","year":"2014","unstructured":"Yano H, Tamura Y, Kobayashi K, Tanemoto M, Uchida S. Uric acid transporter ABCG2 is increased in the intestine of the 5\/6 nephrectomy rat model of chronic kidney disease. Clin Exp Nephrol. 2014;18:50\u20135.","journal-title":"Clin Exp Nephrol"},{"key":"2917_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.604219","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lee MTM. Serum urate polygenic risk score can improve gout risk prediction: a large-scale cohort study. Front Genet. 2020;11: 604219.","journal-title":"Front Genet"},{"key":"2917_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","volume":"12","author":"CM Lewis","year":"2020","unstructured":"Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12:44.","journal-title":"Genome Med"},{"key":"2917_CR16","doi-asserted-by":"crossref","unstructured":"Choi SW, O'Reilly PF: PRSice-2: Polygenic Risk Score software for biobank-scale data. Gigascience 2019, 8.","DOI":"10.1093\/gigascience\/giz082"},{"key":"2917_CR17","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1038\/s41598-018-21425-7","volume":"8","author":"CJ Chen","year":"2018","unstructured":"Chen CJ, Tseng CC, Yen JH, Chang JG, Chou WC, Chu HW, Chang SJ, Liao WT. ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study. Sci Rep. 2018;8:3137.","journal-title":"Sci Rep"},{"key":"2917_CR18","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum. 2011;63:3136\u201341.","journal-title":"Arthritis Rheum"},{"key":"2917_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3899\/jrheum.100418","volume":"38","author":"MA McAdams","year":"2011","unstructured":"McAdams MA, Maynard JW, Baer AN, Kottgen A, Clipp S, Coresh J, Gelber AC. Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol. 2011;38:135\u201341.","journal-title":"J Rheumatol"},{"key":"2917_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38: e164.","journal-title":"Nucleic Acids Res"},{"key":"2917_CR21","doi-asserted-by":"publisher","unstructured":"Turner S, D.: qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots. bioRxiv 2014, https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/005165v1.","DOI":"10.1101\/005165v1"},{"key":"2917_CR22","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","volume":"26","author":"RJ Pruim","year":"2010","unstructured":"Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336\u20137.","journal-title":"Bioinformatics"},{"key":"2917_CR23","first-page":"1","volume":"16","author":"J Graham","year":"2006","unstructured":"Graham J, McCormick B, Blay S, Shin JH. LDheatmap: an R function for graphical display of pairwise linkage disequilibria between single nucleotide polymorphisms. J Stat Softw. 2006;16:1\u201310.","journal-title":"J Stat Softw"},{"key":"2917_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12929-020-00691-6","volume":"27","author":"YH Yamamoto","year":"2020","unstructured":"Yamamoto YH, Noda T. Autophagosome formation in relation to the endoplasmic reticulum. J Biomed Sci. 2020;27:97.","journal-title":"J Biomed Sci"},{"issue":"8","key":"2917_CR25","doi-asserted-by":"publisher","first-page":"e201903127","DOI":"10.1083\/jcb.201903127","volume":"219","author":"YH Yamamoto","year":"2020","unstructured":"Yamamoto YH, Kasai A, Omori H, Takino T, Sugihara M, Umemoto T, Hamasaki M, Hatta T, Natsume T, Morimoto RI, et al. ERdj8 governs the size of autophagosomes during the formation process. J Cell Biol. 2020;219(8):e201903127.","journal-title":"J Cell Biol"},{"key":"2917_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1535370219830665","volume":"244","author":"Y Zamudio-Cuevas","year":"2019","unstructured":"Zamudio-Cuevas Y, Fern\u00e1ndez-Torres J, Mart\u00ednez-Nava GA, Mart\u00ednez-Flores K, Ram\u00edrez Olvera A, Medina-Luna D, Hern\u00e1ndez P\u00e9rez AD, Landa-Sol\u00eds C, L\u00f3pez-Reyes A. Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation. Exp Biol Med (Maywood). 2019;244:344\u201351.","journal-title":"Exp Biol Med (Maywood)"},{"key":"2917_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-014-1236-0","volume":"93","author":"WT Liao","year":"2015","unstructured":"Liao WT, You HL, Li C, Chang JG, Chang SJ, Chen CJ. Cyclic GMP-dependent protein kinase II is necessary for macrophage M1 polarization and phagocytosis via toll-like receptor 2. J Mol Med (Berl). 2015;93:523\u201333.","journal-title":"J Mol Med (Berl)"},{"key":"2917_CR28","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1021\/jm100306a","volume":"53","author":"M Ilies","year":"2010","unstructured":"Ilies M, Di Costanzo L, North ML, Scott JA, Christianson DW. 2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I. J Med Chem. 2010;53:4266\u201376.","journal-title":"J Med Chem"},{"key":"2917_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/med.21419","volume":"37","author":"M Pudlo","year":"2017","unstructured":"Pudlo M, Demougeot C, Girard-Thernier C. Arginase inhibitors: a rational approach over one century. Med Res Rev. 2017;37:475\u2013513.","journal-title":"Med Res Rev"},{"key":"2917_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/humu.23545","volume":"39","author":"C Diez-Fernandez","year":"2018","unstructured":"Diez-Fernandez C, Rufenacht V, Gemperle C, Fingerhut R, Haberle J. Mutations and common variants in the human arginase 1 (ARG1) gene: impact on patients, diagnostics, and protein structure considerations. Hum Mutat. 2018;39:1029\u201350.","journal-title":"Hum Mutat"},{"issue":"Pt 3","key":"2917_CR31","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1042\/bj3301405","volume":"330","author":"M Sastre","year":"1998","unstructured":"Sastre M, Galea E, Feinstein D, Reis DJ, Regunathan S. Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines. Biochem J. 1998;330(Pt 3):1405\u20139.","journal-title":"Biochem J"},{"key":"2917_CR32","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/science.7906055","volume":"263","author":"G Li","year":"1994","unstructured":"Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 1994;263:966\u20139.","journal-title":"Science"},{"issue":"2","key":"2917_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1172\/JCI118430","volume":"97","author":"MJ Lortie","year":"1996","unstructured":"Lortie MJ, Novotny WF, Peterson OW, Vallon V, Malvey K, Mendonca M, Satriano J, Insel P, Thomson SC, Blantz RC. Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Invest. 1996;97(2):413\u201320.","journal-title":"J Clin Invest"},{"key":"2917_CR34","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.144.10.3877","volume":"144","author":"JE Albina","year":"1990","unstructured":"Albina JE, Mills CD, Henry WL Jr, Caldwell MD. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol. 1990;144:3877\u201380.","journal-title":"J Immunol"},{"key":"2917_CR35","first-page":"F646","volume":"267","author":"HT Cook","year":"1994","unstructured":"Cook HT, Jansen A, Lewis S, Largen P, O\u2019Donnell M, Reaveley D, Cattell V. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase. Am J Physiol. 1994;267:F646-53.","journal-title":"Am J Physiol"},{"key":"2917_CR36","first-page":"F197","volume":"267","author":"M Ketteler","year":"1994","unstructured":"Ketteler M, Border WA, Noble NA. Cytokines and L-arginine in renal injury and repair. Am J Physiol. 1994;267:F197-207.","journal-title":"Am J Physiol"},{"key":"2917_CR37","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.1074\/jbc.M312226200","volume":"279","author":"R Augustin","year":"2004","unstructured":"Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem. 2004;279:16229\u201336.","journal-title":"J Biol Chem"},{"key":"2917_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/09687680110090456","volume":"18","author":"HG Joost","year":"2001","unstructured":"Joost HG, Thorens B. The extended GLUT-family of sugar\/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol. 2001;18:247\u201356.","journal-title":"Mol Membr Biol"},{"key":"2917_CR39","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0140-6736(70)92269-5","volume":"2","author":"F Stirpe","year":"1970","unstructured":"Stirpe F, Della Corte E, Bonetti E, Abbondanza A, Abbati A, De Stefano F. Fructose-induced hyperuricaemia. Lancet. 1970;2:1310\u20131.","journal-title":"Lancet"},{"key":"2917_CR40","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1096\/fasebj.4.9.2189777","volume":"4","author":"J Hallfrisch","year":"1990","unstructured":"Hallfrisch J. Metabolic effects of dietary fructose. FASEB J. 1990;4:2652\u201360.","journal-title":"FASEB J"},{"key":"2917_CR41","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng.107","volume":"40","author":"A D\u00f6ring","year":"2008","unstructured":"D\u00f6ring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, Fischer G, Henke K, Klopp N, Kronenberg F, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008;40:430\u20136.","journal-title":"Nat Genet"},{"key":"2917_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10157-011-0532-z","volume":"16","author":"N Anzai","year":"2012","unstructured":"Anzai N, Jutabha P, Amonpatumrat-Takahashi S, Sakurai H. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies. Clin Exp Nephrol. 2012;16:89\u201395.","journal-title":"Clin Exp Nephrol"},{"key":"2917_CR43","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/MNH.0b013e328363ffc8","volume":"22","author":"H Sakurai","year":"2013","unstructured":"Sakurai H. Urate transporters in the genomic era. Curr Opin Nephrol Hypertens. 2013;22:545\u201350.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2917_CR44","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/15257770.2011.633953","volume":"30","author":"A Nakayama","year":"2011","unstructured":"Nakayama A, Matsuo H, Takada T, Ichida K, Nakamura T, Ikebuchi Y, Ito K, Hosoya T, Kanai Y, Suzuki H, et al. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans. Nucleosides Nucleotides Nucleic Acids. 2011;30:1091\u20137.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2917_CR45","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"OM Woodward","year":"2009","unstructured":"Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A. 2009;106:10338\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2917_CR46","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1124\/mol.105.011080","volume":"67","author":"G Merino","year":"2005","unstructured":"Merino G, van Herwaarden AE, Wagenaar E, Jonker JW, Schinkel AH. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP\/ABCG2) in liver. Mol Pharmacol. 2005;67:1765\u201371.","journal-title":"Mol Pharmacol"},{"key":"2917_CR47","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10654-020-00604-9","volume":"34","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ. Adventures in the environment and genes. Eur J Epidemiol. 2019;34:1111\u20137.","journal-title":"Eur J Epidemiol"},{"key":"2917_CR48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","volume":"26","author":"N Mars","year":"2020","unstructured":"Mars N, Koskela JT, Ripatti P, Kiiskinen TTJ, Havulinna AS, Lindbohm JV, Ahola-Olli A, Kurki M, Karjalainen J, Palta P, et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers. Nat Med. 2020;26:549\u201357.","journal-title":"Nat Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02917-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02917-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02917-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T19:41:19Z","timestamp":1678218079000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02917-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2917"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02917-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"4 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the China Medical University Hospital Institutional Review Board in Taiwan (CMUH108-REC1-091) approved this project. Both the Declaration of Helsinki and the Good Clinical Practice Guidelines were followed and informed consent was written by all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Taiwan Biobank obtained written informed consent from each participant, and we got Taiwan Biobank approval for this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}